The Bionics Institute is proud to be collaborating with Bionic Vision Technologies who today announced the interim results of a pilot study involving four patients with late-stage Retinitis Pigmentosa (RP) implanted with a visual prosthesis designed to improve awareness of external objects and patient surroundings.

This two-year pilot study, being conducted at the Centre for Eye Research Australia (CERA) and the Bionics Institute in Melbourne, Australia, involves four adult participants with near total blindness caused by the inherited retinal disease, Retinitis Pigmentosa.  Each study participant was unilaterally implanted with the BVT Gen2 suprachoroidal visual prosthesis in the eye with the least remaining vision.  Mobility testing was initiated after a two-month surgical healing period followed by a 16-week period of vision rehabilitation training.  Participants were asked to complete a series of six tests at 17 weeks following training and then at three monthly intervals from week 20 with the device turned both “on” and “off” to assess performance.  Data has been collected up to 44 weeks for all patients and will continue to be collected for up to 104 weeks.  

To read the full press release click here